Giuseppe Curigliano, MD, PhD: In the Face of COVID, Continuity in Cancer Care

March 05, 2021 By The ASCO Post Staff

Giuseppe Curigliano, MD, PhD, of the University of Milan and Istituto Europeo Oncologico, talks about designing public health measures focused on COVID-19 morbidity and mortality for cancer patients, defining treatment and vaccine priorities, and creating a model to assess the impact of control measures (Symposium 6).

Related Content